268 related articles for article (PubMed ID: 25635535)
1. Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.
Wu Z; Yu Y; Liu C; Xiong Y; Montani JP; Yang Z; Ming XF
Aging (Albany NY); 2015 Jan; 7(1):70-81. PubMed ID: 25635535
[TBL] [Abstract][Full Text] [Related]
2. Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging.
Yepuri G; Velagapudi S; Xiong Y; Rajapakse AG; Montani JP; Ming XF; Yang Z
Aging Cell; 2012 Dec; 11(6):1005-16. PubMed ID: 22928666
[TBL] [Abstract][Full Text] [Related]
3. p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity.
Yu Y; Rajapakse AG; Montani JP; Yang Z; Ming XF
Cardiovasc Diabetol; 2014 Jul; 13():113. PubMed ID: 25034973
[TBL] [Abstract][Full Text] [Related]
4. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.
Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF
J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324
[TBL] [Abstract][Full Text] [Related]
5. Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling.
Zhu C; Yu Y; Montani JP; Ming XF; Yang Z
BMC Res Notes; 2017 Feb; 10(1):82. PubMed ID: 28153047
[TBL] [Abstract][Full Text] [Related]
6. Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling.
Xiong Y; Fru MF; Yu Y; Montani JP; Ming XF; Yang Z
Aging (Albany NY); 2014 May; 6(5):369-79. PubMed ID: 24860943
[TBL] [Abstract][Full Text] [Related]
7. p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs.
Koo BH; Won MH; Kim YM; Ryoo S
Cells; 2020 Feb; 9(2):. PubMed ID: 32046324
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38mapk Reduces Adipose Tissue Inflammation in Aging Mediated by Arginase-II.
Huang J; Liu C; Ming XF; Yang Z
Pharmacology; 2020; 105(9-10):491-504. PubMed ID: 32454488
[TBL] [Abstract][Full Text] [Related]
9. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis.
Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF
Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation.
Mazrouei S; Sharifpanah F; Caldwell RW; Franz M; Shatanawi A; Muessig J; Fritzenwanger M; Schulze PC; Jung C
Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1398-1411. PubMed ID: 31150695
[TBL] [Abstract][Full Text] [Related]
11. Arginase-II activates mTORC1 through myosin-1b in vascular cell senescence and apoptosis.
Yu Y; Xiong Y; Montani JP; Yang Z; Ming XF
Cell Death Dis; 2018 Feb; 9(3):313. PubMed ID: 29472548
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation.
Cai Z; Lu Q; Ding Y; Wang Q; Xiao L; Song P; Zou MH
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2366-73. PubMed ID: 26381869
[TBL] [Abstract][Full Text] [Related]
13. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
14. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
Chen C; Jiang J; Lü JM; Chai H; Wang X; Lin PH; Yao Q
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H193-201. PubMed ID: 20435848
[TBL] [Abstract][Full Text] [Related]
15. Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca
Koo BH; Lee J; Jin Y; Lim HK; Ryoo S
BMB Rep; 2021 Oct; 54(10):516-521. PubMed ID: 34078530
[TBL] [Abstract][Full Text] [Related]
16. Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol.
Rajapakse AG; Yepuri G; Carvas JM; Stein S; Matter CM; Scerri I; Ruffieux J; Montani JP; Ming XF; Yang Z
PLoS One; 2011 Apr; 6(4):e19237. PubMed ID: 21544240
[TBL] [Abstract][Full Text] [Related]
17. Arginase II inhibition prevents interleukin-8 production through regulation of p38 MAPK phosphorylation activated by loss of mitochondrial membrane potential in nLDL-stimulated hAoSMCs.
Koo BH; Yi BG; Jeong MS; Kwon SH; Hoe KL; Kwon YG; Won MH; Kim YM; Ryoo S
Exp Mol Med; 2018 Feb; 50(2):e438. PubMed ID: 29391541
[TBL] [Abstract][Full Text] [Related]
18. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
[TBL] [Abstract][Full Text] [Related]
19. Redox-sensitive up-regulation of eNOS by purple grape juice in endothelial cells: role of PI3-kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a.
Alhosin M; Anselm E; Rashid S; Kim JH; Madeira SV; Bronner C; Schini-Kerth VB
PLoS One; 2013; 8(3):e57883. PubMed ID: 23533577
[TBL] [Abstract][Full Text] [Related]
20. Arginase II Contributes to the Ca
Koo BH; Hwang HM; Yi BG; Lim HK; Jeon BH; Hoe KL; Kwon YG; Won MH; Kim YM; Berkowitz DE; Ryoo S
J Am Heart Assoc; 2018 Sep; 7(18):e009579. PubMed ID: 30371203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
